INCY vs TECH · P/E 14, rev $4.24B vs P/E 65, rev $1.22B
Incyte Corporation (INCY) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported INCY revenue for 2024-12-31 was $4.24B. Net income was $32.6M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the INCY and TECH stock pages for the full models.
Not investment advice.